Literature DB >> 9167126

The American Diabetes Association's Clinical Practice Recommendations and the developing world.

J Akhter.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9167126     DOI： 10.2337/diacare.20.6.1044b

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

1.  Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).

Authors:  Muthiah Vaduganathan; Alessandra Dei Cas; Robert J Mentz; Stephen J Greene; Sadiya Khan; Haris P Subacius; Ovidiu Chioncel; Aldo P Maggioni; Marvin A Konstam; Michele Senni; Gregg C Fonarow; Javed Butler; Mihai Gheorghiade
Journal:  Am J Cardiol       Date:  2014-06-24       Impact factor: 2.778

2.  Diabetes impairs hematopoietic stem cell mobilization by altering niche function.

Authors:  Francesca Ferraro; Stefania Lymperi; Simón Méndez-Ferrer; Borja Saez; Joel A Spencer; Beow Y Yeap; Elena Masselli; Gallia Graiani; Lucia Prezioso; Elisa Lodi Rizzini; Marcellina Mangoni; Vittorio Rizzoli; Stephen M Sykes; Charles P Lin; Paul S Frenette; Federico Quaini; David T Scadden
Journal:  Sci Transl Med       Date:  2011-10-12       Impact factor: 17.956

3.  Glucose tolerance is negatively associated with circulating progenitor cell levels.

Authors:  G P Fadini; L Pucci; R Vanacore; I Baesso; G Penno; A Balbarini; R Di Stefano; R Miccoli; S de Kreutzenberg; A Coracina; A Tiengo; C Agostini; S Del Prato; A Avogaro
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

4.  Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients.

Authors:  D Ma; W Zhu; S Hu; X Yu; Y Yang
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

5.  Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study.

Authors:  Valentina Spigoni; Raffaella Aldigeri; Monica Antonini; Maria Maddalena Micheli; Federica Fantuzzi; Andrea Fratter; Marzia Pellizzato; Eleonora Derlindati; Ivana Zavaroni; Riccardo C Bonadonna; Alessandra Dei Cas
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

6.  Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.

Authors:  Alessandra Dei Cas; Valentina Spigoni; Monia Cito; Raffaella Aldigeri; Valentina Ridolfi; Elisabetta Marchesi; Michela Marina; Eleonora Derlindati; Rosalia Aloe; Riccardo C Bonadonna; Ivana Zavaroni
Journal:  Cardiovasc Diabetol       Date:  2017-02-23       Impact factor: 9.951

7.  Predictors of self-monitoring of blood glucose among noninsulin-treated patients with type 2 diabetes in a primary care setting in Hong Kong: A cross-sectional study.

Authors:  Wing-Hang Mak; Rebecca Wing-Man Lau
Journal:  SAGE Open Med       Date:  2021-12-22

8.  Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.

Authors:  Valentina Spigoni; Angela Picconi; Monia Cito; Valentina Ridolfi; Sabrina Bonomini; Chiara Casali; Ivana Zavaroni; Luigi Gnudi; Marco Metra; Alessandra Dei Cas
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.